Cardiac involvement in systemic lupus erythematosus

被引:238
作者
Doria, A
Iaccarino, L
Sarzi-Puttini, P
Atzeni, F
Turriel, M
Petri, M
机构
[1] Univ Padua, Div Rheumatol, I-35128 Padua, Italy
[2] L Sacco Univ Hosp, Rheumatol Unit, Milan, Italy
[3] Univ Milan, Ist Ortoped Galeazzi, Dept Cardiol, Milan, Italy
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
diagnosis; echocardiography; heart; pathogenesis; systemic lupus erythematosus; treatment;
D O I
10.1191/0961203305lu2200oa
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pericarditis is the most common cardiac abnormality in systemic lupus erythematosus (SLE) patients, but lesions of the valves, myocardiurn and coronary vessels may all occur. In the past, cardiac manifestations were severe and life threatening, often leading to death. Therefore, they were frequently found in post-mortem examinations. Nowadays cardiac manifestations are often mild and asymptomatic. However, they can be frequently recognized by echocardiography and other noninvasive tests. Echocardiography is a sensitive and specific technique in detecting cardiac abnormalities, particularly mild pericarditis, valvular lesions and myocardial dysfunction. Therefore, echocardiography should be performed periodically in SLE patients. Vascular occlusion, including coronary arteries, may develop due to vasculitis, premature atherosclerosis or antiphospholipid antibodies associated with SLE. Premature atherosclerosis is the most frequent cause of coronary artery disease (CAD) in SLE patients. Efforts should be made to control traditional risk factors as well as all other factors which could contribute to atherosclerotic plaque development.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 34 条
[1]  
ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
[2]   IMMUNOPATHOLOGY OF CARDIAC LESIONS IN FATAL SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BIDANI, AK ;
ROBERTS, JL ;
SCHWARTZ, MM ;
LEWIS, EJ .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (06) :849-858
[3]   Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies:: a prospective controlled study [J].
Brucato, A ;
Doria, A ;
Frassi, M ;
Castellino, G ;
Franceschini, F ;
Faden, D ;
Pisoni, MP ;
Solerte, L ;
Muscarà, M ;
Lojacono, A ;
Motta, M ;
Cavazzana, I ;
Ghirardello, A ;
Vescovi, F ;
Tombini, V ;
Cimaz, R ;
Gambari, P ;
Meroni, PL ;
Canesi, B ;
Tincani, A .
LUPUS, 2002, 11 (11) :716-721
[4]   HEART IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND CHANGES INDUCED IN IT BY CORTICOSTEROID-THERAPY - STUDY OF 36 NECROPSY PATIENTS [J].
BULKLEY, BH ;
ROBERTS, WC .
AMERICAN JOURNAL OF MEDICINE, 1975, 58 (02) :243-264
[5]   Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy [J].
Comín-Colet, J ;
Sánchez-Corral, MA ;
Alegre-Sancho, JJ ;
Valverde, J ;
López-Gómez, D ;
Sabaté, X ;
Juan-Mas, A ;
Esplugas, E .
LUPUS, 2001, 10 (01) :59-62
[6]  
DCRUZ D, 2001, DUBOIS LUPUS ERYTHEM, P645
[7]   CARDIOVASCULAR MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
DOHERTY, NE ;
SIEGEL, RJ .
AMERICAN HEART JOURNAL, 1985, 110 (06) :1257-1265
[8]   Inflammation and accelerated atherosclerosis: Basic mechanisms [J].
Doria, A ;
Sherer, Y ;
Meroni, PL ;
Shoenfeld, Y .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (02) :355-+
[9]  
Doria A, 2004, HANDB SYST AUTOIMMUN, V1, P145
[10]  
Doria A, 2004, NEW ENGL J MED, V350, P1571